Liège, Belgium – Mithra Pharmaceuticals, leader in Women’s Health and cutting-edge technological company in the field of API slow-release drugs based on polymere (subcutaneous implants, biocompatible rings, hormonal IUD’s),announced today its participation to the 34th edition of the annual J.P. Morgan Healthcare Conference which is held from 11 to 15 January 2016 in San Francisco.
Share it
Latest news
Mithra announces updates to its 2024 financial calendar
28 March 2024
Mithra reports full year 2023 financial results
8 March 2024